| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.33 | 5e-12 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.28 | 4e-08 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.25 | 6e-07 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.21 | 0.0001 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.14 | 0.01 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.096 | 0.07 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.087 | 0.1 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.09 | 0.1 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.08 | 0.2 |